Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.
Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S, Tian N, Lin S, Lu Q, Wu X, Li Q, Liu Z, Chen Y, Qian X, Wang J, Chai D, Chen C, Li X, Gogas BD, Pan T, Shan S, Ye F, Chen SL.
J Am Coll Cardiol. 2018 Dec 18;72(24):3126-3137. doi: 10.1016/j.jacc.2018.09.013. Epub 2018 Sep 24.
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation.
Gao XF, Ge Z, Kong XQ, Kan J, Han L, Lu S, Tian NL, Lin S, Lu QH, Wang XY, Li QH, Liu ZZ, Chen Y, Qian XS, Wang J, Chai DY, Chen CH, Pan T, Ye F, Zhang JJ, Chen SL; ULTIMATE Investigators.
JACC Cardiovasc Interv. 2021 Feb 8;14(3):247-257. doi: 10.1016/j.jcin.2020.10.001. Epub 2020 Oct 29.
New drug-eluting stent concepts.
Wessely R.
Nat Rev Cardiol. 2010 Apr;7(4):194-203. doi: 10.1038/nrcardio.2010.14. Epub 2010 Mar 2.
Biodegradable-Polymer Versus Polymer-Free Drug-Eluting Stents for the Treatment of Coronary Artery Disease.
Nogic J, Thein P, Mirzaee S, Comella A, Soon K, Cameron JD, West NEJ, Brown AJ.
Cardiovasc Revasc Med. 2019 Oct;20(10):865-870. doi: 10.1016/j.carrev.2018.12.010. Epub 2018 Dec 14.
Biodegradable-Polymer Drug-Eluting Stent Platforms: The Importance of Long-Term Outcomes.
Kutcher MA.
JACC Cardiovasc Interv. 2018 May 28;11(10):1003-1005. doi: 10.1016/j.jcin.2018.04.025.
Drug loaded implantable devices to treat cardiovascular disease.
Adhami M, Martin NK, Maguire C, Courtenay AJ, Donnelly RF, Domínguez-Robles J, Larrañeta E.
Expert Opin Drug Deliv. 2023 Apr;20(4):507-522. doi: 10.1080/17425247.2023.2190580. Epub 2023 Mar 28.
Fully bioresorbable drug-eluting coronary scaffolds: A review.
Charpentier E, Barna A, Guillevin L, Juliard JM.
Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):385-97. doi: 10.1016/j.acvd.2015.03.009. Epub 2015 Jun 22.
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.
Zhang Y, Wu Z, Wang S, Liu T, Liu J.
Cardiovasc Drugs Ther. 2023 Dec;37(6):1155-1166. doi: 10.1007/s10557-022-07363-7. Epub 2022 Aug 5.
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW; ILUMIEN III: OPTIMIZE PCI Investigators.
Lancet. 2016 Nov 26;388(10060):2618-2628. doi: 10.1016/S0140-6736(16)31922-5. Epub 2016 Oct 30.
Coronary drug-eluting stents: from design optimization to newer strategies.
Sun D, Zheng Y, Yin T, Tang C, Yu Q, Wang G.
J Biomed Mater Res A. 2014 May;102(5):1625-40. doi: 10.1002/jbm.a.34806. Epub 2013 Jul 1.
